menu search

KZR / Wall Street Analysts Think Kezar Life Sciences, Inc. (KZR) Could Surge 135%: Read This Before Placing a Bet

Wall Street Analysts Think Kezar Life Sciences, Inc. (KZR) Could Surge 135%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 135.4% in Kezar Life Sciences, Inc. (KZR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. Read More
Posted: Jun 30 2022, 11:44
Author Name: Zacks Investment Research
Views: 101887

KZR News  

Kezar (KZR) Falls 10% on Strategic Update, Reduces Workforce

By Zacks Investment Research
October 4, 2023

Kezar (KZR) Falls 10% on Strategic Update, Reduces Workforce

Kezar (KZR) falls 10% on the decision to channel resources to one clinical candidate as part of its reprioritization efforts and slash the workforce b more_horizontal

Kezar Life Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

By Business Wire
January 4, 2023

Kezar Life Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and develo more_horizontal

Kezar Life Sciences: Mid-Term Growth Levers Heavily Discounted, Reduce To Hold

By Seeking Alpha
November 16, 2022

Kezar Life Sciences: Mid-Term Growth Levers Heavily Discounted, Reduce To Hold

Following a shift in market sentiment, I've narrowed my rating for Kezar Life Sciences from buy to hold. The market has heavily discounted KZR's growt more_horizontal

Wall Street Analysts Think Kezar Life Sciences, Inc. (KZR) Could Surge 135%: Read This Before Placing a Bet

By Zacks Investment Research
June 30, 2022

Wall Street Analysts Think Kezar Life Sciences, Inc. (KZR) Could Surge 135%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 135.4% in Kezar Life Sciences, Inc. (KZR). While the effectiv more_horizontal

Biotech Stock Blasts Higher After Upbeat Trial Data

By Schaeffers Research
June 28, 2022

Biotech Stock Blasts Higher After Upbeat Trial Data

Kezar Life Sciences Inc (NASDAQ:KZR) is skyrocketing today, up 84.1% at $10.55, after positive results from a mid-stage study of its kidney disorder d more_horizontal

After-Hours Action: Why Kezar Life Sciences Stock Is Soaring

By Benzinga
June 27, 2022

After-Hours Action: Why Kezar Life Sciences Stock Is Soaring

Kezar Life SciencesĀ Inc (NASDAQ: KZR) shares are surging in Monday's after-hours session after the company announced topline results from the MISSION more_horizontal

Should You Buy Kezar (KZR) Ahead of Earnings?

By Zacks Investment Research
May 10, 2022

Should You Buy Kezar (KZR) Ahead of Earnings?

Kezar (KZR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. more_horizontal


Search within

Pages Search Results: